⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 10, 2024Perspectives in Clinical ResearchOpen Access

Comparative efficacy and safety of gabapentin, pregabalin, oxcarbazepine, and duloxetine in diabetic peripheral neuropathy: A network meta-analysis

Karan Bhavesh Shah Devang Rana Yash Dharmendra Mehta Supriya Deepak Malhotra

View Full Paper

Ask AI

Bookmark

Share

Abstract

To conduct a network meta-analysis comparing the safety and efficacy of gabapentin (GBP), pregabalin (PGB), oxcarbazepine (OXC), and duloxetine (DLX) in treating diabetic peripheral neuropathy (DPN).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shah et al. (2024) studied this question.

synapsesocial.com/papers/68e60cdbb6db64358759fcd0 https://doi.org/10.4103/picr.picr_218_23

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Evaluating the efficacy and safety of duloxetine and gabapentin in managing diabetic neuropathy: A systematic review and meta-analysis2025 · 4 citations
2Comparison of efficacy of carbamazepine and duloxetiene for the treatment of diabetic neuropathy.2024
3Pregabalin and duloxetine combination for painful diabetic neuropathy: a systematic review and meta-analysisMeta-Analysis · 2026
4Pregabalin versus oxcarbazepine in painful diabetic neuropathy in elderly population: Efficacy and safety in terms of pain relief, cognitive function, and overall quality of lifeOriginal Research · 2018 · 3 citations
5Comparative study of pregabalin and carbamazepine in painful diabetic peripheral neuropathy at the tertiary care hospital2024